aluates Reports

$ 0.0

Automative

Global Immunotherapeutic Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-13E18900

BUY CHAPTERS

Global Immunotherapeutic Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-13E18900

Report

December 2024

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Merck

Novartis

Johnson & Johnson

GlaxoSmithKline PLC

AbbVie

Eli Lilly

Amgen Inc

Astrazeneca plc

Bristol-Mysers Squibb

Immunotherapeutic Drugs Market Size

The global Immunotherapeutic Drugs market is projected to grow from US$ 199710 million in 2024 to US$ 379440 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.3% during the forecast period.

Immunotherapeutic Drugs Market

Immunotherapy is a cancer treatment that enhances the body's natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.

Market Analysis and Insights: Global Immunotherapeutic Drugs Market

The US & Canada market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Immunotherapeutic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Immunotherapeutic Drugs include Roche, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie, ELI Lilly, Amgen and AstraZeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Immunotherapeutic Drugs is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Immunotherapeutic Drugs industry development. In 2023, global % revenue of Immunotherapeutic Drugs went into Hospitals filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Immunotherapeutic Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Immunotherapeutic Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunotherapeutic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunotherapeutic Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Immunotherapeutic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immunotherapeutic Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Immunotherapeutic Drugs Market Report

Report Metric	Details
Report Name	Immunotherapeutic Drugs Market
Accounted market size in 2024	US$ 199710 in million
Forecasted market size in 2030	US$ 379440 million
CAGR	11.3
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Monoclonal Antibody Vaccines Checkpoint Inhibitor Interferon
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie, ELI Lilly, Amgen, AstraZeneca, Bristol-Mysers Squibb
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immunotherapeutic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapeutic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunotherapeutic Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Immunotherapeutic Drugs Market growing?

Ans: The Immunotherapeutic Drugs Market witnessing a CAGR of 11.3 during the forecast period 2025-2030.

What is the Immunotherapeutic Drugs Market size in 2030?

Ans: The Immunotherapeutic Drugs Market size in 2030 will be US$ 379440 million.

Who are the main players in the Immunotherapeutic Drugs Market report?

Ans: The main players in the Immunotherapeutic Drugs Market are Roche, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie, ELI Lilly, Amgen, AstraZeneca, Bristol-Mysers Squibb

What are the Application segmentation covered in the Immunotherapeutic Drugs Market report?

Ans: The Applications covered in the Immunotherapeutic Drugs Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Immunotherapeutic Drugs Market report?

Ans: The Types covered in the Immunotherapeutic Drugs Market report are Monoclonal Antibody, Vaccines, Checkpoint Inhibitor, Interferon

Recommended Reports

Cancer Therapy Markets

Oncology Drug Markets

Immunotherapy & Allergy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibody

1.2.3 Vaccines

1.2.4 Checkpoint Inhibitor

1.2.5 Interferon

1.3 Market by Application

1.3.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immunotherapeutic Drugs Market Perspective (2019-2030)

2.2 Global Immunotherapeutic Drugs Growth Trends by Region

2.2.1 Immunotherapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Immunotherapeutic Drugs Historic Market Size by Region (2019-2024)

2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Region (2025-2030)

2.3 Immunotherapeutic Drugs Market Dynamics

2.3.1 Immunotherapeutic Drugs Industry Trends

2.3.2 Immunotherapeutic Drugs Market Drivers

2.3.3 Immunotherapeutic Drugs Market Challenges

2.3.4 Immunotherapeutic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Immunotherapeutic Drugs by Players

3.1.1 Global Immunotherapeutic Drugs Revenue by Players (2019-2024)

3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Immunotherapeutic Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Immunotherapeutic Drugs Market Concentration Ratio

3.4.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2023

3.5 Global Key Players of Immunotherapeutic Drugs Head office and Area Served

3.6 Global Key Players of Immunotherapeutic Drugs, Product and Application

3.7 Global Key Players of Immunotherapeutic Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immunotherapeutic Drugs Breakdown Data by Type

4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2019-2024)

4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2025-2030)

5 Immunotherapeutic Drugs Breakdown Data by Application

5.1 Global Immunotherapeutic Drugs Historic Market Size by Application (2019-2024)

5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Immunotherapeutic Drugs Market Size (2019-2030)

6.2 North America Immunotherapeutic Drugs Market Size by Type

6.2.1 North America Immunotherapeutic Drugs Market Size by Type (2019-2024)

6.2.2 North America Immunotherapeutic Drugs Market Size by Type (2025-2030)

6.2.3 North America Immunotherapeutic Drugs Market Share by Type (2019-2030)

6.3 North America Immunotherapeutic Drugs Market Size by Application

6.3.1 North America Immunotherapeutic Drugs Market Size by Application (2019-2024)

6.3.2 North America Immunotherapeutic Drugs Market Size by Application (2025-2030)

6.3.3 North America Immunotherapeutic Drugs Market Share by Application (2019-2030)

6.4 North America Immunotherapeutic Drugs Market Size by Country

6.4.1 North America Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Immunotherapeutic Drugs Market Size by Country (2019-2024)

6.4.3 North America Immunotherapeutic Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Immunotherapeutic Drugs Market Size (2019-2030)

7.2 Europe Immunotherapeutic Drugs Market Size by Type

7.2.1 Europe Immunotherapeutic Drugs Market Size by Type (2019-2024)

7.2.2 Europe Immunotherapeutic Drugs Market Size by Type (2025-2030)

7.2.3 Europe Immunotherapeutic Drugs Market Share by Type (2019-2030)

7.3 Europe Immunotherapeutic Drugs Market Size by Application

7.3.1 Europe Immunotherapeutic Drugs Market Size by Application (2019-2024)

7.3.2 Europe Immunotherapeutic Drugs Market Size by Application (2025-2030)

7.3.3 Europe Immunotherapeutic Drugs Market Share by Application (2019-2030)

7.4 Europe Immunotherapeutic Drugs Market Size by Country

7.4.1 Europe Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Immunotherapeutic Drugs Market Size by Country (2019-2024)

7.4.3 Europe Immunotherapeutic Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Immunotherapeutic Drugs Market Size (2019-2030)

8.2 China Immunotherapeutic Drugs Market Size by Type

8.2.1 China Immunotherapeutic Drugs Market Size by Type (2019-2024)

8.2.2 China Immunotherapeutic Drugs Market Size by Type (2025-2030)

8.2.3 China Immunotherapeutic Drugs Market Share by Type (2019-2030)

8.3 China Immunotherapeutic Drugs Market Size by Application

8.3.1 China Immunotherapeutic Drugs Market Size by Application (2019-2024)

8.3.2 China Immunotherapeutic Drugs Market Size by Application (2025-2030)

8.3.3 China Immunotherapeutic Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Immunotherapeutic Drugs Market Size (2019-2030)

9.2 Asia Immunotherapeutic Drugs Market Size by Type

9.2.1 Asia Immunotherapeutic Drugs Market Size by Type (2019-2024)

9.2.2 Asia Immunotherapeutic Drugs Market Size by Type (2025-2030)

9.2.3 Asia Immunotherapeutic Drugs Market Share by Type (2019-2030)

9.3 Asia Immunotherapeutic Drugs Market Size by Application

9.3.1 Asia Immunotherapeutic Drugs Market Size by Application (2019-2024)

9.3.2 Asia Immunotherapeutic Drugs Market Size by Application (2025-2030)

9.3.3 Asia Immunotherapeutic Drugs Market Share by Application (2019-2030)

9.4 Asia Immunotherapeutic Drugs Market Size by Region

9.4.1 Asia Immunotherapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Immunotherapeutic Drugs Market Size by Region (2019-2024)

9.4.3 Asia Immunotherapeutic Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Immunotherapeutic Drugs Introduction

11.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.1.5 Roche Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Immunotherapeutic Drugs Introduction

11.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.2.5 Merck Recent Developments

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Immunotherapeutic Drugs Introduction

11.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.3.5 Novartis Recent Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction

11.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.4.5 Johnson & Johnson Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction

11.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.5.5 GlaxoSmithKline Recent Developments

11.6 AbbVie

11.6.1 AbbVie Company Details

11.6.2 AbbVie Business Overview

11.6.3 AbbVie Immunotherapeutic Drugs Introduction

11.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.6.5 AbbVie Recent Developments

11.7 ELI Lilly

11.7.1 ELI Lilly Company Details

11.7.2 ELI Lilly Business Overview

11.7.3 ELI Lilly Immunotherapeutic Drugs Introduction

11.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.7.5 ELI Lilly Recent Developments

11.8 Amgen

11.8.1 Amgen Company Details

11.8.2 Amgen Business Overview

11.8.3 Amgen Immunotherapeutic Drugs Introduction

11.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.8.5 Amgen Recent Developments

11.9 AstraZeneca

11.9.1 AstraZeneca Company Details

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Immunotherapeutic Drugs Introduction

11.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.9.5 AstraZeneca Recent Developments

11.10 Bristol-Mysers Squibb

11.10.1 Bristol-Mysers Squibb Company Details

11.10.2 Bristol-Mysers Squibb Business Overview

11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction

11.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2019-2024)

11.10.5 Bristol-Mysers Squibb Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche

Merck

Novartis

Johnson & Johnson

GlaxoSmithKline PLC

AbbVie

Eli Lilly

Amgen Inc

Astrazeneca plc

Bristol-Mysers Squibb

List of Tables

Table 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibody

Table 3. Key Players of Vaccines

Table 4. Key Players of Checkpoint Inhibitor

Table 5. Key Players of Interferon

Table 6. Global Immunotherapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Immunotherapeutic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Immunotherapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Immunotherapeutic Drugs Market Share by Region (2019-2024)

Table 10. Global Immunotherapeutic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Immunotherapeutic Drugs Market Share by Region (2025-2030)

Table 12. Immunotherapeutic Drugs Market Trends

Table 13. Immunotherapeutic Drugs Market Drivers

Table 14. Immunotherapeutic Drugs Market Challenges

Table 15. Immunotherapeutic Drugs Market Restraints

Table 16. Global Immunotherapeutic Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Immunotherapeutic Drugs Revenue Share by Players (2019-2024)

Table 18. Global Top Immunotherapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2023)

Table 19. Global Immunotherapeutic Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Immunotherapeutic Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Immunotherapeutic Drugs, Headquarters and Area Served

Table 22. Global Key Players of Immunotherapeutic Drugs, Product and Application

Table 23. Global Key Players of Immunotherapeutic Drugs, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Immunotherapeutic Drugs Revenue Market Share by Type (2019-2024)

Table 27. Global Immunotherapeutic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Immunotherapeutic Drugs Revenue Market Share by Type (2025-2030)

Table 29. Global Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Immunotherapeutic Drugs Revenue Share by Application (2019-2024)

Table 31. Global Immunotherapeutic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Immunotherapeutic Drugs Revenue Share by Application (2025-2030)

Table 33. North America Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Immunotherapeutic Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Immunotherapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Immunotherapeutic Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Immunotherapeutic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 65. Roche Company Details

Table 66. Roche Business Overview

Table 67. Roche Immunotherapeutic Drugs Product

Table 68. Roche Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 69. Roche Recent Developments

Table 70. Merck Company Details

Table 71. Merck Business Overview

Table 72. Merck Immunotherapeutic Drugs Product

Table 73. Merck Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 74. Merck Recent Developments

Table 75. Novartis Company Details

Table 76. Novartis Business Overview

Table 77. Novartis Immunotherapeutic Drugs Product

Table 78. Novartis Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 79. Novartis Recent Developments

Table 80. Johnson & Johnson Company Details

Table 81. Johnson & Johnson Business Overview

Table 82. Johnson & Johnson Immunotherapeutic Drugs Product

Table 83. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 84. Johnson & Johnson Recent Developments

Table 85. GlaxoSmithKline Company Details

Table 86. GlaxoSmithKline Business Overview

Table 87. GlaxoSmithKline Immunotherapeutic Drugs Product

Table 88. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 89. GlaxoSmithKline Recent Developments

Table 90. AbbVie Company Details

Table 91. AbbVie Business Overview

Table 92. AbbVie Immunotherapeutic Drugs Product

Table 93. AbbVie Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 94. AbbVie Recent Developments

Table 95. ELI Lilly Company Details

Table 96. ELI Lilly Business Overview

Table 97. ELI Lilly Immunotherapeutic Drugs Product

Table 98. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 99. ELI Lilly Recent Developments

Table 100. Amgen Company Details

Table 101. Amgen Business Overview

Table 102. Amgen Immunotherapeutic Drugs Product

Table 103. Amgen Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 104. Amgen Recent Developments

Table 105. AstraZeneca Company Details

Table 106. AstraZeneca Business Overview

Table 107. AstraZeneca Immunotherapeutic Drugs Product

Table 108. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 109. AstraZeneca Recent Developments

Table 110. Bristol-Mysers Squibb Company Details

Table 111. Bristol-Mysers Squibb Business Overview

Table 112. Bristol-Mysers Squibb Immunotherapeutic Drugs Product

Table 113. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2019-2024) & (US$ Million)

Table 114. Bristol-Mysers Squibb Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Immunotherapeutic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Immunotherapeutic Drugs Market Share by Type: 2023 VS 2030

Figure 3. Monoclonal Antibody Features

Figure 4. Vaccines Features

Figure 5. Checkpoint Inhibitor Features

Figure 6. Interferon Features

Figure 7. Global Immunotherapeutic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Immunotherapeutic Drugs Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Other Case Studies

Figure 12. Immunotherapeutic Drugs Report Years Considered

Figure 13. Global Immunotherapeutic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Immunotherapeutic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Immunotherapeutic Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global Immunotherapeutic Drugs Market Share by Players in 2023

Figure 17. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2023

Figure 19. North America Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Immunotherapeutic Drugs Market Share by Type (2019-2030)

Figure 21. North America Immunotherapeutic Drugs Market Share by Application (2019-2030)

Figure 22. North America Immunotherapeutic Drugs Market Share by Country (2019-2030)

Figure 23. United States Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Immunotherapeutic Drugs Market Share by Type (2019-2030)

Figure 27. Europe Immunotherapeutic Drugs Market Share by Application (2019-2030)

Figure 28. Europe Immunotherapeutic Drugs Market Share by Country (2019-2030)

Figure 29. Germany Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Immunotherapeutic Drugs Market Share by Type (2019-2030)

Figure 37. China Immunotherapeutic Drugs Market Share by Application (2019-2030)

Figure 38. Asia Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Immunotherapeutic Drugs Market Share by Type (2019-2030)

Figure 40. Asia Immunotherapeutic Drugs Market Share by Application (2019-2030)

Figure 41. Asia Immunotherapeutic Drugs Market Share by Region (2019-2030)

Figure 42. Japan Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Immunotherapeutic Drugs Market Share by Country (2019-2030)

Figure 52. Brazil Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Immunotherapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 59. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 60. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 61. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 62. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 63. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 64. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 65. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 66. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 67. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Immunotherapy Drugs Market Research Report 2024

Cancer Immunotherapy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Global Cancer Immunotherapy Market Insights Forecast to 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Cancer Immunotherapies Market Insights Forecast to 2030

Global Immunocell Therapy Market Insights Forecast to 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global T Cell Immunotherapy Market Research Report 2025

Global Immuno Cell Therapy Market Research Report 2024

Global Cancer Biotherapy Market Insights Forecast to 2030

Global Melanoma Drugs Market Insights Forecast to 2030

Global Immune Cell Therapy Drugs Market Research Report 2025

Tumor Immunotherapy Market

Global Immuno Oncology Treatment Market Insights Forecast to 2030

Global CAR T Cell Immunotherapy Market Insights Forecast to 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions